Takeda prepping to take over EU production of stem cell therapy from 2021 – BioPharma-Reporter.com
|
Takeda prepping to take over EU production of stem cell therapy from 2021
BioPharma-Reporter.com Following its acceptance for review by the European Medicines Agency (EMA), Takeda and TiGenix announced this week Swissmedic has accepted for review the file for compound Cx601, an allogeneic expanded adipose-derived stem cell (eASC) therapy … |
